Neuren Pharmaceuticals LimitedASX: NEU

Neuren FDA meeting confirms Phase 3 plan for Rett syndrome

Oct 13, 2017 at 2:20 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment